Regen Biopharma Inc (RGBAD)

[Meach2]

Basically in the last few days I have seen Koos drop at least 4 million shares on investors (again) for the cost of around 400,000 dollars. Looks like Koos is getting his yearly paycheque of over $300,000 dollars U.S. per year (In a failing company with no revenues) so he can sail his boat on our dime.

SURE IS A NICE BOAT! http://www.phrfsandiego.org/certificate.php?CertificateID=1615

http://oracledispatch.com/2016/09/16/whats-the-real-story-on-regen-biopharma-inc-otcbbrgbp/

"Regen BioPharma, Inc. entered into a definitive agreement with Eli Lilly and Company which allows Regen to receive compounds from Lilly for drug discovery purposes and allows Regen to share structural information on compounds of mutual interest. However, note that this is not an agreement that has any cost or risk to Eli Lilly, so it’s likely not something that’s particularly difficult to achieve. And it’s not going to provide funding."

"because it takes an average of $400 mln in funding to develop and commercialize a cancer therapy through biotechnological pathways, and the company is sitting on a war chest of less than $150k in cash, the real story is the company’s claim that it can find “non-dilutive funding”."

"There’s no such thing as a free lunch."